ArticleBMC cardiovascular disorders2022

Custodiol HTK versus Plegisol: in-vitro comparison with the use of immature (H9C2) and mature (HCM) cardiomyocytes cultures.

Rafał Nowicki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.